Genomate Wins Blue Earth Summit BE100 in Health

LONDON, October 20, 2026: Genomate Health has been named one of ten BE100 winners at Blue Earth Summit 2026, taking first place in the Health category. Each winner will receive at least £100,000 from BE100 Fund II, which Blue Earth manages with venture capital firm Haatch. The recognition is already adding momentum to Genomate Health’s fundraising, with further investor meetings ahead in Berlin.

The winners were selected from 1,414 applicants across ten industries, with one winner chosen in each. A panel of 40 judges from venture capital and industry assessed commercial viability, positive impact, innovation, team strength and competitive position, based on applications, pitch decks and short live presentations.

“The most exciting thing about this win is what it could mean for a patient who has never heard of Genomate. We’ve spent years building technology that helps doctors choose the right targeted therapy for each patient, based on the unique combination of mutations driving their tumor. But our vision goes beyond supporting decisions. We set out to conquer cancer with the power of mathematics, created by human intelligence and accelerated by the power of computation. We hope that Blue Earth’s support will open doors to take this work further, reaching the patients we want to help and the partners who can help us bring this solution to the world as quickly as possible.” said Dr. Istvan Petak, Founder and Chief Scientific Officer of Genomate Health.

The award comes at a pivotal moment for precision oncology. AI has multiplied the output of drug discovery, and hundreds of promising new molecules are now waiting for clinical trials. Genomate Health’s technology is designed to help bring these drugs to the cancer patients who need them, as quickly as possible.

Blue Earth intends its investment to act as a catalyst, helping winners attract further backers and reach new customers through its network. For Genomate Health, that support opens the door to new partnerships and to reaching more patients worldwide.

Read the full announcement of the 2026 BE100 winners: IT Brief UK

‍

‍

‍